XBI State Street SPDR S&P Biote...


$ 113.80 $ -0.67 (-0.59 %)    

Thursday, 20-Nov-2025 16:42:37 EST
QQQ $ 584.62 $ -14.20 (-2.37 %)
DIA $ 458.30 $ -3.66 (-0.79 %)
SPY $ 652.19 $ -10.10 (-1.52 %)
TLT $ 89.30 $ 0.35 (0.39 %)
GLD $ 375.00 $ -0.11 (-0.03 %)
$ 113.83
$ 116.15
$ 113.84 x 160
$ 113.86 x 110
$ 113.74 - $ 117.90
$ 66.64 - $ 117.90
13,951,567
na
na
$ 1.06
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Rotating To Healthcare

 taiwan-semiconductor-healthequity-cboe-global-markets-and-more-cnbcs-final-trades

Stephen Weiss of Short Hills Capital Partners, named Taiwan Semiconductor Manufacturing Company as his final trade.

 biotech-etfs-come-alive-as-illumina-soars-23--is-the-genomics-winter-finally-over

Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China...

 top-6-etfs-to-watch-as-wall-streets-strongest-six-months-begin

As markets enter their strongest stretch, ETFs tied to AI, banking, and healthcare could shine. Here's where investors are ...

 intellia-freezes-key-trial-after-serious-liver-event-stock-tumbles

Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related advers...

 scisparc-expands-biotech-ambitions-buys-stake-in-miza-iii-ventures

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...

 4-biotech-stocks-seeing-explosive-momentum-gains

The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here...

 how-trumps-shutdown-standoff-could-hand-health-care-etfs-a-lifeline

Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' rada...

 scisparc-and-automax-call-off-merger

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

 crowdstrike-sofi-clearway-energy-and-more-cnbcs-final-trades

Experts on CNBC's Halftime Report discussed top trades for the day. SoFi hit an all-time high, Clearway Energy has strong d...

 trumps-biotech-playbook-ignites-350-billion-investment-blitz

Trump's policies have sparked a $350B investment surge in US biotech, creating job & revenue opportunities. Investors c...

 hedge-funds-are-building-a-towering-wall-of-bets-against-stocks

After a sharp 23% rebound in the S&P 500 since April, hedge funds are now stacking record levels of bearish bets against st...

 novavax-scores-key-fda-win-shares-jump-19-as-sanofi-unlocks-milestone-payment

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial dist...

 vinay-prasads-appointment-to-fdas-cber-triggers-questions-over-future-of-cell-and-gene-therapy-regulation

FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst...

Core News & Articles

https://news.bloomberglaw.com/health-law-and-business/fda-names-vinay-prasad-as-new-head-of-vaccines-biologics

 moderna-novavax-shares-are-tumbling-monday-whats-going-on

Vaccine stocks are trading lower Monday following a shakeup at the U.S. Food and Drug Administration.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION